Long-term prognosis of hypertrophic cardiomyopathy after surgery

Sandhya K Balaram1, Daniel G Swistel

  • 1Division of Cardiovascular and Thoracic Surgery, St. Luke's/Roosevelt Hospital Center, New York, NY, USA. dswistel@chpnet.org.

Insights

Septal myectomy significantly improves symptoms and reduces left ventricular outflow tract obstruction in hypertrophic cardiomyopathy patients. This surgical therapy has demonstrated consistent benefits with decreased morbidity and mortality over 40 years.

Area of Science:

  • Cardiovascular Surgery
  • Cardiology
  • Medical Treatment Outcomes

Background:

  • Hypertrophic cardiomyopathy (HCM) is a complex condition with varied treatment strategies.
  • Symptomatic patients with significant left ventricular outflow tract (LVOT) obstruction often require intervention.
  • Septal myectomy is a primary surgical option for managing obstructive HCM.

Purpose of the Study:

  • To review the historical and current outcomes of surgical septal myectomy for hypertrophic cardiomyopathy.
  • To evaluate symptom improvement, morbidity, mortality, and long-term survival post-procedure.
  • To assess the safety and efficacy of septal myectomy in specialized centers.

Main Methods:

  • Literature review focusing on early and recent studies of septal myectomy outcomes.
  • Analysis of data from specialized centers with high patient volumes for septal myectomy.
  • Assessment of symptom relief, LVOT gradient reduction, and survival rates.

Main Results:

  • Surgical therapy for HCM has shown consistent symptom improvement and LVOT gradient reduction over four decades.
  • Significant decreases in morbidity and mortality associated with septal myectomy have been observed.
  • Improvements are attributed to advancements in cardiac surgery techniques and understanding of HCM pathophysiology.

Conclusions:

  • Septal myectomy is a safe, reproducible, and effective procedure for symptomatic patients with obstructive HCM.
  • The procedure leads to substantial improvements in patient symptoms and long-term survival.
  • Continued advancements in surgical techniques enhance the positive outcomes of septal myectomy.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...